Search Results 841-850 of 15970 for larazotide acetate

  1. A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This is a multicenter, multiple dose study to examine the effect of H.P. Acthar® (Acthar) on functional decline in adult subjects with amyotrophic lateral ...

  2. Pasireotide (subcutaneous route, intramuscular route) - Mayo Clinic

    Pasireotide injection is also used for the treatment of acromegaly (a growth hormone disorder) in patients who cannot be treated with surgery. Signifor® is ...

  3. A Study to Develop a Resource (bank) of Biospecimens and Data Collected from Individuals with Liver Disease and Without Liver Disease - Mayo Clinic

    About this study. The purpose of this study is to facilitate discovery and development of novel biomarkers of risk and early detection, etiologic factors ...

  4. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now - Mayo Clinic

    REVOLUTION will be a US multicenter observational registry in scope and governed by a steering committee of approximately 8 experts in NSCLC and outcomes ...

  5. Establishment of Preclinical Models from Patients with Gynecological Malignancies - Mayo Clinic

    In this study, we make and test preclinical models of gynecological cancers (ovarian, fallopian tube, peritoneal, uterine, vulvar, cervix, and vaginal) of any ...

  6. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

    Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. Participation eligibility.

  7. A Study to Evaluate the Long-Term Safety and Effectiveness of Caplacizumab for Patients who Completed Study ALX0681-C301 - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Clinical and Laboratory Review of Patients with Myeloid Disorders

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Osimertinib (oral route) - Mayo Clinic

    Osimertinib is used to treat non-small cell lung cancer (NSCLC) in patients who have certain types of abnormal epidermal growth factor (EGFR) genes. This ...

  10. Laboratories - Mayo Clinic Research

    L. Lipotoxicity and Liver Inflammation: Samar H. Ibrahim · Liquid Biopsy and Translational Immunogenomics: Aadel A. Chaudhuri · Liver Disease Immunobiology: ...